Characterization of hyaluronan and TSG-6 in skin scarring: Differential distribution in keloid scars, normal scars and unscarred skin

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 3, 2011, Pages 317-327

  Tan, K T ^a,b,c   McGrouther, D A ^a,b   Day, A J ^c   Milner, C M ^c   Bayat, A ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

hyaluronan; inter inhibitor; keloid; scarring; TSG 6

Indexed keywords

GENE PRODUCT; HYALURONIC ACID; TSG 6 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNICITY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; INFLAMMATION; KELOID; KERATINOCYTE; MALE; PRIORITY JOURNAL; SKIN APPENDAGE; SKIN SCAR; TISSUE REPAIR; TUMOR NECROSIS FACTOR STIMULATED GENE 6;

ADOLESCENT; ADULT; AGED; ALPHA-GLOBULINS; CELL ADHESION MOLECULES; CICATRIX; EXTRACELLULAR MATRIX; FEMALE; HUMANS; HYALURONIC ACID; KELOID; MALE; MIDDLE AGED; SKIN; YOUNG ADULT;

EID: 79751477074     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03792.x     Document Type: Article

References (43)

1. Ferguson MWJ, Whitby DJ, Shah M, Armstrong J, Siebert JW, Longaker MT,. Scar formation: the spectral nature of fetal and adult wound repair. Plast Reconstr Surg 1996; 97: 854-860. (Pubitemid 26089457)
2. Marneros AG, Norris JEC, Watanabe S, Reichenberger E, Olsen BR,. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 2004; 122: 1126-1132. (Pubitemid 38651086)
3. Chen Y, Gao JH, Liu XJ, Yan X, Song M,. Linkage analysis of keloid susceptibility loci on chromosome 7p11 in a Chinese pedigree. Nan fang yi ke da xue xue bao (Journal of Southern Medical University) 2006; 26: 623-637.
4. Bayat A, McGrouther DA,. Clinical management of skin scarring. Skinmed 2005; 4: 165-173.
5. Marneros AG, Krieg T,. Keloids - clinical diagnosis, pathogenesis, and treatment options. J Dtsch Dermatol Ges 2004; 2: 905-913. (Pubitemid 39472352)
6. Bayat A, McGrouther DA, Ferguson MW,. Skin scarring. Br Med J 2003; 326: 88-92. (Pubitemid 36092292)
7. Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP,. Keloid pathogenesis and treatment. Plast Reconstr Surg 2006; 117: 286-300. (Pubitemid 44391579)
8. Davis KD, Garcia M., Phillips J.A., et al. Detection of a critical interval for a familial keloid locus on chromosome 14q22-q23 in an African-American pedigree. Am J Hum Gen 2000; 67: A21.
9. Evanko SP, Tammi MI, Tammi RH, Wight TN,. Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev 2007; 59: 1351-1365. (Pubitemid 350088257)
10. Broughton G II, Janis JE, Attinger CE,. The basic science of wound healing. Plast Reconstr Surg 2006; 117 (7 Suppl.): 601-609.
11. Chen WYJ, Abatangelo G,. Functions of hyaluronan in wound repair. Wound Repair Regen 1999; 7: 79-89. (Pubitemid 29200045)
12. Nentwich HA, Mustafa Z, Rugg MS, et al. A novel allelic variant of the human TSG-6 gene encoding an amino acid difference in the CUB module. Chromosomal localization, frequency analysis, modeling, and expression. J Biol Chem 2002; 277: 15354-15362. (Pubitemid 34967797)
13. Lee TH, Wisniewski HG, Vilcek J,. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J Cell Biol 1992; 116: 545-557.
14. Milner CM, Day AJ,. TSG-6: a multifunctional protein associated with inflammation. J Cell Sci 2003; 116: 1863-1873. (Pubitemid 36622285)
15. Milner CM, Higman VA, Day AJ,. TSG-6: a pluripotent inflammatory mediator? Biochem Soc Trans 2006; 34: 446-450. (Pubitemid 43954008)
16. Sanggaard KW, Sonne-Schmidt CS, Krogager TP, et al. TSG-6 transfers proteins between glycosaminoglycans via a Ser-28-mediated covalent catalytic mechanism. J Biol Chem 2008; 283: 33919-33926.
17. Milner CM, Tongsoongnoen W, Rugg MS, Day AJ,. The molecular basis of inter-α-inhibitor heavy chain transfer on to hyaluronan. Biochem Soc Trans 2007; 35: 672-676. (Pubitemid 47310338)
18. Rugg MS, Willis AC, Mukhopadhyay D, et al. Characterization of complexes formed between TSG-6 and inter-α- inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan. J Biol Chem 2005; 280: 25674-25686. (Pubitemid 40962277)
19. Yingsung W, Zhuo L, Morgelin M, et al. Molecular heterogeneity of the SHAP-hyaluronan complex: Isolation and characterization of the complex in synovial fluid from patients with rheumatoid arthritis. J Biol Chem 2003; 278: 32710-32718. (Pubitemid 37055710)
20. Day AJ, De La Motte CA,. Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol 2005; 26: 637-643. (Pubitemid 41628196)
21. Fulop C, Szanto S, Mukhopadhyay D, et al. Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice. Development 2003; 130: 2253-2261. (Pubitemid 36656719)
22. Zhuo L, Kanamori A, Kannagi R, et al. SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum. J Biol Chem 2006; 281: 20303-20314. (Pubitemid 44065805)
23. Fujimoto T, Savani RC, Watari M, Day AJ, Strauss JF III,. Induction of the hyaluronic acid-binding protein, tumor necrosis factor-stimulated gene-6, in cervical smooth muscle cells by tumor necrosis factor-α and prostaglandin E2. Am J Pathol 2002; 160: 1495-1502. (Pubitemid 34411652)
24. Yoshihara Y, Plaas A, Osborn B, et al. Superficial zone chondrocytes in normal and osteoarthritic human articular cartilages synthesize novel truncated forms of inter-alpha-trypsin inhibitor heavy chains which are attached to a chondroitin sulfate proteoglycan other than bikunin. Osteoarthritis Cartilage 2008; 16: 1343-1355.
25. Forteza R, Casalino-Matsuda SM, Monzon ME, et al. TSG-6 potentiates the antitissue kallikrein activity of inter-α-inhibitor through bikunin release. Am J Respir Cell Mol Biol 2007; 36: 20-31. (Pubitemid 46067704)
26. Mahoney DJ, Mikecz K, Ali T, et al. TSG-6 regulates bone remodelling through inhibition of osteoblastogenesis and osteoclast activation. J Biol Chem 2008; 283: 25952-25962.
27. Lee TH, Lee GW, Ziff EB, Vilcek J,. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol Cell Biol 1990; 10: 1982-1988.
28. Bayliss MT, Howat SLT, Dudhia J, et al. Up-regulation and differential expression of the hyaluronan-binding protein TSG-6 in cartilage and synovium in rheumatoid arthritis and osteoarthritis. Osteoarthritis Cartilage 2001; 9: 42-48. (Pubitemid 32154916)
29. Mukhopadhyay D, Hascall VC, Day AJ, Salustri A, Fulop C,. Two distinct populations of tumor necrosis factor-stimulated gene-6 protein in the extracellular matrix of expanded mouse cumulus cell-oocyte complexes. Arch Biochem Biophys 2001; 394: 173-181. (Pubitemid 32989326)
30. Ochsner SA, Day AJ, Rugg MS, Breyer RM, Gomer RH, Richards JS,. Disrupted function of tumor necrosis factor-α-stimulated gene 6 blocks cumulus cell-oocyte complex expansion. Endocrinology 2003; 144: 4376-4384. (Pubitemid 37204836)
31. Ochsner SA, Russell DL, Day AJ, Breyer RM, Richards JS,. Decreased expression of tumor necrosis factor-α-stimulated gene 6 in cumulus cells of the cyclooxygenase-2 and EP2 null mice. Endocrinology 2003; 144: 1008-1019. (Pubitemid 36262868)
32. Candi E, Schmidt R, Melino G,. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328-340. (Pubitemid 40516899)
33. Fuchs E,. Scratching the surface of skin development. Nature 2007; 445: 834-842.
34. Simpson RML, Meran S, Thomas D, et al. Age-related changes in pericellular Hyaluronan Organization leads to impaired Dermal fibroblast to myofibroblast differentiation. Am J Pathol 2009; 175: 1915-1928.
35. Getting SJ, Mahoney DJ, Cao T, et al. The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan- and inter-α-inhibitor- independent manner. J Biol Chem 2002; 277: 51068-51076. (Pubitemid 36042279)
36. Wisniewski HG, Hua JC, Poppers DM, Naime D, Vilcek J, Cronstein BN,. TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-α-inhibitor and exerts a strong anti-inflammatory effect in vivo. J Immunol 1996; 156: 1609-1615.
37. Lee RH, Pulin AA, Seo MJ, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5: 54-63.
38. Meyer LJM, Russell SB, Russell JD, et al. Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol 2000; 114: 953-959. (Pubitemid 30252717)
39. Bertheim U, Hellstrom S,. The distribution of hyaluronan in human skin and mature, hypertrophic and keloid scars. Br J Plast Surg 1994; 47: 483-489. (Pubitemid 24309460)
40. Tammi R, Agren UM, Tuhkanen AL, Tammi M,. Hyaluronan metabolism in skin. Prog Histochem Cytochem 1994; 29: 1-81.
41. Wang C, Tammi M, Tammi R,. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 1992; 98: 105-112.
42. Alaish SM, Yager DR, Diegelmann RF, Cohen IK,. Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg 1995; 30: 949-952.
43. Boraldi F, Croce MA, Quaglino D, et al. Cell-matrix interactions of in vitro human skin fibroblasts upon addition of hyaluronan. Tissue Cell 2003; 35: 37-45. (Pubitemid 36329259)